Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression

Current Opinion in Behavioral Sciences

Volumn 14, Issue , 2017, Pages 1-8

  Ghosal, Sriparna ^a   Hare, Brendan D ^a   Duman, Ronald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT;

BRAIN REGION; CHRONIC STRESS; DEPRESSION; GABAERGIC TRANSMISSION; HUMAN; INTERNEURON; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW;

EID: 84992221165     PISSN: None     EISSN: 23521546     Source Type: Journal    
DOI: 10.1016/j.cobeha.2016.09.012     Document Type: Review

References (61)

1. 1 Duman, R.S., Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress Anxiety 31 (2014), 291–296, 10.1002/da.22227 Epub 2014/03/13. PubMed PMID: 24616149; PubMed Central PMCID: PMC4432471.
2. 2 Popoli, M., Yan, Z., McEwen, B.S., Sanacora, G., The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci 13 (2012), 22–37, 10.1038/nrn3138 Epub 2011/12/01. PubMed PMID: 22127301; PubMed Central PMCID: PMC3645314.
3. 3 Goto, Y., Yang, C.R., Otani, S., Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol Psychiatry 67 (2010), 199–207, 10.1016/j.biopsych.2009.08.026 Epub 2009/10/17. PubMed PMID: 19833323.
4. 4 Hains, A.B., Arnsten, A.F., Molecular mechanisms of stress-induced prefrontal cortical impairment: implications for mental illness. Learning Memory 15 (2008), 551–564, 10.1101/lm.921708 Epub 2008/08/08. PubMed PMID: 18685145.
5. 5 Drevets, W.C., Price, J.L., Furey, M.L., Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213 (2008), 93–118, 10.1007/s00429-008-0189-x Epub 2008/08/16. PubMed PMID: 18704495; PubMed Central PMCID: PMC2522333.
6. 6 Banasr, M., Valentine, G.W., Li, X.Y., Gourley, S.L., Taylor, J.R., Duman, R.S., Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 62 (2007), 496–504, 10.1016/j.biopsych.2007.02.006 Epub 2007/06/26. PubMed PMID: 17585885.
7. 7• Ota, K.T.L.R., Voleti, B., Maldonado-Aviles, J.G., Duric, V., Iwata, M., Dutheil, S., Duman, C., Boikess, S., Lewis, D.A., Stockmeier, C.A., et al. REDD1 is essential for stress-induced synaptic loss and depressive behavior. Nat Med 20 (2014), 531–535 Epub 2014 Apr 13. This study provided evidence that REDD1 is a critical mediator of the atrophy of neurons and depressive behavior caused by chronic stress exposure in both human and preclinical model.
8. 8 Radley, J.J., Morrison, J.H., Repeated stress and structural plasticity in the brain. Ageing Res Rev 4 (2005), 271–287, 10.1016/j.arr.2005.03.004 Epub 2005/07/05. PubMed PMID: 15993654.
9. 9 Duman, R.S., Monteggia, L.M., A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (2006), 1116–1127, 10.1016/j.biopsych.2006.02.013 Epub 2006/04/25. PubMed PMID: 16631126.
10. 10 Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., Wu, C., Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5 (2004), 793–807, 10.1038/nrn1519 Epub 2004/09/21. PubMed PMID: 15378039.
11. 11 Gassmann, M., Bettler, B., Regulation of neuronal GABA(B) receptor functions by subunit composition. Nat Rev Neurosci 13 (2012), 380–394, 10.1038/nrn3249 Epub 2012/05/19. PubMed PMID: 22595784.
12. 12 Luscher, B., Fuchs, T., GABAergic control of depression-related brain states. Advan Pharmacol 73 (2015), 97–144, 10.1016/bs.apha.2014.11.003 Epub 2015/02/01. PubMed PMID: 25637439; PubMed Central PMCID: PMC4784429.
13. 13• Sanacora, G., Mason, G.F., Rothman, D.L., Behar, K.L., Hyder, F., Petroff, O.A., Berman, R.M., Charney, D.S., Krystal, J.H., Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56 (1999), 1043–1047 Epub 1999/11/24. PubMed PMID: 10565505. This study provided the first evidence that GABA levels are reduced in depression.
14. 14 Hasler, G., van der Veen, J.W., Tumonis, T., Meyers, N., Shen, J.W.C.D., Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 (2007), 193–200 Epub 2007/02/07.
15. 15 Hasler, G., Neumeister, A., van der Veen, J.W., Tumonis, T., Bain, E.E., Shen, J., Drevets, W.C., Charney, D.S., Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 58 (2005), 969–973, 10.1016/j.biopsych.2005.05.017 Epub 2005/07/27. PubMed PMID: 16043137.
16. 16 Dubin, M.J., Mao, X., Banerjee, S., Goodman, Z., Lapidus, K.A., Kang, G., Liston, C., Shungu, D.C., Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy. J Psychiatry Neurosci 41 (2016), E37–E45 Epub 2016/02/24. PubMed PMID: 26900793; PubMed Central PMCID: PMC4853214.
17. 17 Vaiva, G., Thomas, P., Ducrocq, F., Fontaine, M., Boss, V., Devos, P., Rascle, C., Cottencin, O., Brunet, A., Laffargue, P.M.G., Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol Psychiatry 55 (2004), 250–254 Epub 2004/01/28.
18. 18 Vaiva, G., Boss, V., Ducrocq, F., Fontaine, M., Devos, P., Brunet, A., Laffargue, P., Goudemand, M.P.T., Relationship between posttrauma GABA plasma levels and PTSD at 1-year follow-up. Am J Psychiatry 163 (2006), 1446–1448 Epub 2006/08/01.
19. 19 Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M.O., Anisman, H., Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24 (2004), 1478–1485, 10.1523/JNEUROSCI. 4734-03.2004 Epub 2004/02/13. PubMed PMID: 14960621.
20. 20 Poulter, M.O., Du, L., Weaver, I.C., Palkovits, M., Faludi, G., Merali, Z., Szyf, M., Anisman, H., GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 64 (2008), 645–652, 10.1016/j.biopsych.2008.05.028 Epub 2008/07/22. PubMed PMID: 18639864.
21. 21 Choudary, P.V., Molnar, M., Evans, S.J., Tomita, H., Li, J.Z., Vawter, M.P., Myers, R.M., Bunney, W.E. Jr., Akil, H., Watson, S.J., Jones, E.G., Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102 (2005), 15653–15658, 10.1073/pnas.0507901102 Epub 2005/10/19. PubMed PMID: 16230605; PubMed Central PMCID: PMC1257393.
22. 22 Sequeira, A., Klempan, T., Canetti, L., ffrench-Mullen, J., Benkelfat, C., Rouleau, G.A.G.T., Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 12 (2007), 640–655 Epub 2007/03/14.
23. 23 Geuze, E., van Berckel, B.N., Lammertsma, A.A., Boellaard, R., de Kloet, C.S., Vermetten, E., Westenberg, H.G., Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol Psychiatry 13 (2008), 74–83, 10.1038/sj.mp.4002054 Epub 2007/08/02. PubMed PMID: 17667960, 3.
24. 24 Klumpers, U.M., Veltman, D.J., Drent, M.L., Boellaard, R., Comans, E.F., Meynen, G., Lammertsma, A.A., Hoogendijk, W.J., Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. Eur J Nuclear Med Mol Imaging 37 (2010), 565–574, 10.1007/s00259-009-1292-9 Epub 2009/11/06. PubMed PMID: 19890631.
25. 25 Karolewicz, B., Maciag, D., O'Dwyer, G., Stockmeier, C.A., Feyissa, A.M., Rajkowska, G., Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. Int J Neuropsychopharmacol/Official Scientific J Collegium Internationale Neuropsychopharmacologicum 13 (2010), 411–420, 10.1017/S1461145709990587 Epub 2010/03/20. PubMed PMID: 20236554; PubMed Central PMCID: PMC2857696.
26. 26 Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C.A., Miguel-Hidalgo, J.J., GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32 (2007), 471–482, 10.1038/sj.npp.1301234 Epub 2006/10/26. PubMed PMID: 17063153; PubMed Central PMCID: PMC2771699.
27. 27 Maciag, D., Hughes, J., O'Dwyer, G., Pride, Y., Stockmeier, C.A., Sanacora, G., Rajkowska, G., Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry 67 (2010), 465–470, 10.1016/j.biopsych.2009.10.027 Epub 2009/12/17. PubMed PMID: 20004363; PubMed Central PMCID: PMC2823848.
28. 28 Lin, L.C., Sibille, E., Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?. Front Pharmacol, 4, 2013, 110, 10.3389/fphar.2013.00110 Epub 013/09/24. PubMed PMID: 24058344; PubMed Central PMCID: PMC3766825.
29. 29 Duman, R.S., Aghajanian, G.K., Sanacora, G., Krystal, J.H., Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 22 (2016), 238–249, 10.1038/nm.4050 Epub 2016/03/05. PubMed PMID: 26937618.
30. 30 Smith, K.S.U.R., Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes. Neuropharmacology 62 (2012), 54–62.
31. 31 Shen, Q., Lal, R., Luellen, B.A., Earnheart, J.C., Andrews, A.M., Luscher, B., gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic–pituitary–adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol Psychiatry 68 (2010), 512–520, 10.1016/j.biopsych.2010.04.024 Epub 2010/06/29. PubMed PMID: 20579975; PubMed Central PMCID: PMC2930197.
32. 32• Ren, Z., Pribiag, H., Jefferson, S.J., Shorey, M., Fuchs, T., Stellwagen, D., Luscher, B., Bidirectional homeostatic regulation of a depression-related brain state by gamma-aminobutyric acidergic deficits and ketamine treatment. Biol Psychiatry, 2016, 10.1016/j.biopsych.2016.02.009 Epub 2016/04/12. PubMed PMID: 27062563; PubMed Central PMCID: PMC4983262. This study examined the consequences of diminished GABA receptor function in regulating synaptic integrity within the PFC and shows that ketamine reverses these GABA deficits.
33. 33 Caldji, C., Francis, D., Sharma, S., Plotsky, P.M., Meaney, M.J., The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. Neuropsychopharmacology 22 (2000), 219–229, 10.1016/S0893-133X(99)00110-4 Epub 2000/02/29. PubMed PMID: 10693149.
34. 34 Acosta, G.B., Otero Losada, M.E., Rubio, M.C., Area-dependent changes in GABAergic function after acute and chronic cold stress. Neurosci Lett 154 (1993), 175–178 Epub 1993/05/14. PubMed PMID: 8361637.
35. 35 Braestrup, C., Nielsen, M., Nielsen, E.B.M.L., Benzodiazepine receptors in the brain as affected by different experimental stresses: the changes are small and not undirectional. Psychopharmacology (Berl) 65 (1979), 273–277.
36. 36 Matsumoto, K., Puia, G., Dong, E.G.P., GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders. Stress 10 (2007), 3–12.
37. 37 Bloomfield, C., French, S.J., Jones, D.N., Reavill, C., Southam, E., Cilia, J., Totterdell, S., Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats. Synapse 62 (2008), 628–631, 10.1002/syn.20521 Epub 2008/05/31. PubMed PMID: 18512213.
38. 38 Shepard, R., Page, C.E.L.C., Sensitivity of the prefrontal GABAergic system to chronic stress in male and female mice: Relevance for sex differences in stress-related disorders. Neuroscience 332 (2016), 1–12.
39. 39• Zhang, W., Zhang, L., Liang, B., Schroeder, D., Zhang, Z.W., Cox, G.A., Li, Y., Lin, D.T., Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders. Nat Neurosci 19 (2016), 557–559, 10.1038/nn.4257 Epub 2016/02/24. PubMed PMID: 26900927; PubMed Central PMCID: PMC4811704. This study used optogentics and cell selective approaches to show that SST-mediated disinhibition of pyramidal neurons occurs via inhibition of PV interneurons.
40. 40 Seybold, B.A., Stanco, A., Cho, K.K., Potter, G.B., Kim, C., Sohal, V.S., Rubenstein, J.L., Schreiner, C.E., Chronic reduction in inhibition reduces receptive field size in mouse auditory cortex. Proc Natl Acad Sci U S A 109 (2012), 13829–13834, 10.1073/pnas.1205909109 Epub 2012/07/04. PubMed PMID: 22753490; PubMed Central PMCID: PMC3427089.
41. 41 Li, N., Liu, R.J., Dwyer, J.M., Banasr, M., Lee, B., Son, H., Li, X.Y., Aghajanian, G., Duman, R.S., Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69 (2011), 754–761, 10.1016/j.biopsych.2010.12.015 Epub 2011/02/05. PubMed PMID: 21292242; PubMed Central PMCID: PMC3068225.
42. 42 Courtin, J., Chaudun, F., Rozeske, R.R., Karalis, N., Gonzalez-Campo, C., Wurtz, H., Abdi, A., Baufreton, J., Bienvenu, T.C., Herry, C., Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression. Nature 505 (2014), 92–96, 10.1038/nature12755 Epub 2013/11/22. PubMed PMID: 24256726.
43. 43• Sibille, E., Morris, H.M., Kota, R.S., Lewis, D.A., GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol/Official Scientific J Collegium Internationale Neuropsychopharmacologicum 14 (2011), 721–734, 10.1017/S1461145710001616 Epub 2011/01/14. PubMed PMID: 21226980; PubMed Central PMCID: PMC3388740. This study provided evidence that supports the idea that PFC GABAergic deficits are highly associated with mood disorders.
44. 44 Tripp, A., Kota, R.S., Lewis, D.A., Sibille, E., Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Disease 42 (2011), 116–124, 10.1016/j.nbd.2011.01.014 Epub 2011/01/15. PubMed PMID: 21232602; PubMed Central PMCID: PMCPMC3039077.
45. 45 Seney, M.L., Tripp, A., McCune, S., Lewis, D.A., Sibille, E., Laminar and cellular analyses of reduced somatostatin gene expression in the subgenual anterior cingulate cortex in major depression. Neurobiol Dis 73 (2015), 213–219, 10.1016/j.nbd.2014.10.005 Epub 2014/10/16. PubMed PMID: 25315685; PubMed Central PMCID: PMCPMC4394026.
46. 46 Lin, L.C., Sibille, E., Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry 20 (2015), 377–387, 10.1038/mp.2014.184 Epub 2015/01/21. PubMed PMID: 25600109; PubMed Central PMCID: PMCPMC4355106.
47. 47 Soumier, A., Sibille, E., Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology 39 (2014), 2252–2262, 10.1038/npp.2014.76 Epub 2014/04/03. PubMed PMID: 24690741; PubMed Central PMCID: PMCPMC4104344.
48. 48 Perova, Z., Delevich, K., Li, B., Depression of excitatory synapses onto parvalbumin interneurons in the medial prefrontal cortex in susceptibility to stress. J Neurosci 35 (2015), 3201–3206, 10.1523/jneurosci.2670-14.2015 Epub 2015/02/24. PubMed PMID: 25698754; PubMed Central PMCID: PMCPMC4331634.
49. 49 Bhagwagar, Z., Wylezinska, M., Taylor, M., Jezzard, P., Matthews, P.M., Cowen, P.J., Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161 (2004), 368–370, 10.1176/appi.ajp.161.2.368 Epub 2004/02/03. PubMed PMID: 14754790.
50. 50 Sanacora, G., Mason, G.F., Rothman, D.L., Hyder, F., Ciarcia, J.J., Ostroff, R.B., Berman, R.M., Krystal, J.H., Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160 (2003), 577–579, 10.1176/appi.ajp.160.3.577 Epub 2003/03/04. PubMed PMID: 12611844.
51. 51 Goren, M.Z., Kucukibrahimoglu, E., Berkman, K., Terzioglu, B., Fluoxetine partly exerts its actions through GABA: a neurochemical evidence. Neurochem Res 32 (2007), 1559–1565, 10.1007/s11064-007-9357-2 PubMed PMID: WOS: 000248190200016.
52. 52 Chen, A.I., Nguyen, C.N., Copenhagen, D.R., Badurek, S., Minichiello, L., Ranscht, B., Reichardt, L.F., TrkB (tropomyosin-related kinase B) controls the assembly and maintenance of GABAergic synapses in the cerebellar cortex. J Neurosci 31 (2011), 2769–2780, 10.1523/JNEUROSCI. 4991-10.2011 Epub 2011/03/19. PubMed PMID: 21414899; PubMed Central PMCID: PMC3154015.
53. 53 Vithlani, M.H.R., Zhong, P., Terunuma, M., Hines, D.J., Revilla-Sanchez, R., Jurd, R., Haydon, P., Rios, M., Brandon, N., Yan, Z., Moss, S.J., The ability of BDNF to modify neurogenesis and depressive-like behaviors is dependent upon phosphorylation of tyrosine residues 365/367 in the GABA(A)-receptor γ2 subunit. J Neurosci 33 (2013), 155567–155577.
54. 54 Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., Krystal, J.H., Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47 (2000), 351–354 Epub 2000/02/25. PubMed PMID: 10686270.
55. 55 Zarate, C.A. Jr., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63 (2006), 856–864, 10.1001/archpsyc.63.8.856 Epub 2006/08/09. PubMed PMID: 16894061.
56. 56 Voleti, B., Navarria, A., Liu, R.J., Banasr, M., Li, N., Terwilliger, R., Sanacora, G., Eid, T., Aghajanian, G., Duman, R.S., Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 74 (2013), 742–749, 10.1016/j.biopsych.2013.04.025 Epub 2013/06/12. PubMed PMID: 23751205; PubMed Central PMCID: PMC3773272.
57. 57• Li, N., Lee, B., Liu, R.J., Banasr, M., Dwyer, J.M., Iwata, M., Li, X.Y., Aghajanian, G., Duman, R.S., mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329 (2010), 959–964, 10.1126/science.1190287 Epub 2010/08/21. PubMed PMID: 20724638; PubMed Central PMCID: PMC3116441. This is the first direct demonstration of the signaling pathways involved in the antidepressant activity of ketamine.
58. 58• Moghaddam, B., Adams, B., Verma, A., Daly, D., Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997), 2921–2927 Epub 1997/04/15. PubMed PMID: 9092613. This is the first direct demonstration of ketamine-mediated activation of gluatamatrigic neurotransmission in the PFC.
59. 59 Urban-Ciecko, J., Fanselow, E.E., Barth, A.L., Neocortical somatostatin neurons reversibly silence excitatory transmission via GABAb receptors. Curr Biol 25 (2015), 722–731, 10.1016/j.cub.2015.01.035 Epub 2015/03/03. PubMed PMID: 25728691; PubMed Central PMCID: PMC4393017.
60. 60 Wohleb, E.S., Wu, M., Gerhard, D.M., Taylor, S.R., Picciotto, M.R., Alreja, M., Duman, R.S., GABA interneurons mediate the rapid antidepressant-like effects of scopolamine. J Clin Investig 126 (2016), 2482–2494, 10.1172/JCI85033 Epub 2016/06/09. PubMed PMID: 27270172; PubMed Central PMCID: PMC4922686.
61. 61 Newport, D.J., Carpenter, L.L., McDonald, W.M., Potash, J.B., Tohen, M., Nemeroff, C.B., Biomarkers APACoRTFoN, treatments. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression. Am J Psychiatry 172 (2015), 950–966, 10.1176/appi.ajp.2015.15040465 Epub 2015/10/02. PubMed PMID: 26423481.